A Study Of Small Non-Coding RNAs Of Salmonella Enterica Subspecies Enterica Serovar Typhi In Biofilm Development by Anbalagan, Kogaan
A STUDY OF SMALL NON-CODING RNAs OF 
SALMONELLA ENTERICA SUBSPECIES 
ENTERICA SEROVAR TYPHI IN BIOFILM 
DEVELOPMENT 
 
 
 
 
 
 
 
 
 
 
KOGAAN ANBALAGAN 
 
 
 
 
 
 
 
 
 
UNIVERSITI SAINS MALAYSIA 
 
2017 
 
A STUDY OF SMALL NON-CODING RNAs OF 
SALMONELLA ENTERICA SUBSPECIES 
ENTERICA SEROVAR TYPHI IN BIOFILM 
DEVELOPMENT 
 
 
 
 
 
 
 
 
by 
 
 
 
 
 
 
KOGAAN ANBALAGAN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thesis submitted in fulfillment of the requirements 
for the degree of 
Master of Science 
 
 
 
 
 
June 2017 
ii 
 
ACKNOWLEDGEMENT 
 
First and foremost, I would like to thank God for His blessings, His strength, and the 
opportunity to pursue my higher education. I would like to take this opportunity to 
extend my sincere and deepest gratitude to my main supervisor, Professor Dr. Phua 
Kia Kien for his insightful discussions and suggestions during these past three years.  
I would also like to thank my field supervisor, Dr. Suresh Vengkata Chinni for his 
support, guidance and advice. 
 
I would like to especially thank the Institute for Research in Molecular Medicine 
(INFORMM) for providing a place and comfortable environment for me to carry out 
my research. My thanks also goes to all the administration staff, science officers and 
lab office assistants. Special thanks goes for Dr. Eugene Ong who has always been 
pleasant and assisted me during my research. My gratitude also goes to my labmates; 
Estiyag Abdalla Abdal Kareem, Kalaivani Muniandy, Sangeetha Periya, and Goay 
Yuan Xin for their constant support, advice, and ideas. 
 
I am obligated to my family for their financial help, advice, understanding and 
encouragement throughout good and bad times. Without their love, support and 
understanding, I would not have been strong enough to overcome all the obstacles and 
complete my studies in time.  
 
Last but not least, I am very grateful to the Ministry of Higher Education, Government 
of Malaysia for providing tuition fee support through the MyMaster programme, and 
to the Fundamental Research Grant Scheme (203/CIPPM/6711334) for financial 
iii 
 
support via the research assistant programme. Finally, I would like to give credit to 
each and everyone who have helped me, directly and indirectly, in completing my 
research. 
  
iv 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGMENT……………………………………………………………ii 
TABLE OF CONTENTS…………………………………………………………...iv 
LIST OF TABLES..………………………………………………………………...xi 
LIST OF FIGURES……………………………………………………………......xii 
LIST OF SYMBOLS, ABBREVIATIONS AND ACRONYMNS……………….xv 
ABSTRAK…………………………………………………………………………xvi 
ABSTRACT……………………………………………………………………...xviii 
 
CHAPTER ONE: INTRODUCTION……………………………………………...1 
CHAPTER TWO: LITERATURE REVIEW……………………………………..5 
2.1 The Genus Salmonella………………………………………………………...5 
2.2  Salmonella enterica subspecies enterica serovar Typhi………………………5 
2.3 Typhoid Fever………………………………………………………………...5 
2.4  Pathogenesis and Clinical Manifestations…………………………………….8 
2.5 Typhoid Carriers……………………………………………………………. 10 
2.6 Bacterial Biofilm…………………………………………………………….11 
2.7 Life Cycle of Biofilm………………………………………………………..11 
2.8  Salmonella Biofilm Matrix…………………………………………………..13 
2.9 Non-Coding RNA.………………………………………………………….. 15 
2.10 Cis-encoded base pairing Non-Coding RNAs……………………………….16 
2.11 Trans-encoded base pairing Non-Coding RNAs…………………………….17 
2.12 Non-Coding RNA in Biofilm………………………………………………..19 
2. 13 Rational of the Study………………………………………………………...20 
v 
 
2.14 Research Objectives…………………………………………………………22 
 
CHAPTER THREE: MATERIALS AND METHODS…………………………23 
3.1 Materials……………………………………………………………………. 23 
3.1.1 Chemicals, Media and Reagents……………………………………..23 
3.1.2  Research Kits and Consumables……………………………………..23 
3.1.3 Software.…………………………………………………………….23 
3.1.4  Instruments…………………………………………………………..23 
3.1.5 Enzymes…………………………………………………………......23 
3.1.6 Target Specific Oligonucleotides……………………………………23 
3.1.7 Bacteria Isolate………………………………………………………23 
3.1.8 Media Preparation for Bacteria Culturing Purposes…………………28 
3.1.8(a) Nutrient broth……………………………………………….28 
3.1.8(b) Xylose Lysine Deoxycholate (XLD) Agar…………………28 
3.1.8(c) Triple Sugar Iron (TSI) Agar……………………………….29 
3.1.8(d) Simmons Citrate Agar……………………………………...29 
3.1.8(e) Urea Solution (40%)………………………………………..29 
3.1.8(f) Urea Agar Base……………………………………………..29 
3.1.8(g) Sulphate Indole Motility (SIM) Medium…………………..30 
3.1.8(h) Methyl Red Vogas-Proskauer (MRVP) Medium…………..30 
3.1.8(i) Bile Solution………………………………………………...30 
3.1.8(j) Glucose Solution…………………………………………….31 
3.1.8(k) Sodium Chloride (NaCl) Solution…………………………..31 
3.1.8(l) Potassium Chloride (KCl) Solution…………………………31 
3.1.8(m) Crystal Violet Dye…………………………………………31 
vi 
 
3.1.8(n) Ethanol Solution……………………………………………32 
3.1.8(o) Biofilm Culture Media……………………………………...32 
3.1.8(p) Microscope Glass Slide Modification……………………....32 
3.1.8(q) Cholesterol Coating of Microscope Glass Slides…………...32 
3.1.9 Reagents for Northern Blot Analysis 
3.1.9(a) Washing Buffer.…………………………………………….33 
3.1.9(b) Maleic Acid Buffer………………………………………....33 
3.1.9(c) Blocking Solution…………………………………………..33 
3.1.9(d) Detection Buffer……………………………………………33 
3.1.9(e) Antibody Solution…………………………………………..33 
   3.1.9(f) CDP-Star® Chemiluminescent Substrate…………………...34 
3.1.10 Denaturing Urea Polyacrylamide Gel Electrophoresis (Urea PAGE)..34 
3.2 Methods 
3.2.1 Maintenance and Revival of Bacterial Stock………………………...35 
3.2.2 Identification and Verification of Bacterial Strains……………….....35 
3.2.2(a) Biochemical Test…………………………………………...35 
3.2.2(b) Serotyping Test……………………………………………..36 
3.2.3 Biofilm Cell Cultures………………………………………………..36 
3.2.3(a) Biofilm Cell Culture Using 96-well microtiter plates………36 
3.2.3(b) Biofilm Cell Culture Using 2.0 mL micro-centrifuge Tubes.36 
3.2.3(c) Biofilm Cell Culture Using 6-well tissue culture plates……..37 
  3.2.3(c)(i) Biofilm Cell Culture using 6-well  
        Tissue Culture Plates (Model A)………………..37 
  3.2.3(c)(ii) Biofilm Cell Culture Using 6-well Tissue  
        Culture plates with Microscope Glass  
vii 
 
         Slide (Model B)………………………………..37 
   3.2.3(c)(iii) Biofilm Cell Culture using 6-well Tissue  
                      Culture plates with Cholesterol-Coated     
           Microscope Glass Slide (Model C)……………38 
3.2.4 Planktonic Cells Culture……………………………………………..38 
3.2.5 Intermediate Cells Culture…………………………………………...38 
3.2.6 Crystal Violet Assay…………………………………………………39 
3.2.7 Growth Profile of Planktonic Cells, Intermediate Cells  
and Biofilm Cells…………………………………………………….40 
3.2.7(a) Growth Profile of Planktonic Cells…………………………40 
3.2.7(b) Growth Profile of Intermediate Cells……………………….40 
3.2.7(c) Growth Profile of Biofilm Cells…………………………….40 
3.2.8 Cell Morphology of Planktonic Cells, Intermediate Cells and  
Biofilm Cells by Electron Microscopy (EM) Analysis………………40 
3.2.8(a) Cell Morphology of Planktonic Cell and Intermediate Cell..40 
3.2.8(b) Cell Morphology of Biofilm Cells ………………………….40 
3.3 Total RNA Extraction from Planktonic Cells, Intermediate Cells  
and Biofilm Cells…………………………………………………………….41 
3.3.1 Preparation of Planktonic Cells and Intermediate Cells……………..42 
3.3.2 Preparation of Biofilm Cells…………………………………………42 
3.3.3 Total RNA Extraction from Planktonic Cells and Intermediate Cells..42 
3.3.4 Total RNA Extraction from Biofilm Cells…………………………..43 
3.3.4(a) Total RNA Extraction from Biofilm Cells  
  using Commercial Kits……………………………………..44  
3.3.4(b) Total RNA Extraction from Biofilm Cells  
viii 
 
   using Enzymatic Lysis Method…………………………....44 
3.3.4(c) Total RNA Extraction from Biofilm Cells  
  using Sonication Method…………………………………...45 
3.3.4(d) Total RNA Extraction from Biofilm Cells  
  using Bead Beater Method………………………………....46 
3.3.5 DNase Treatment ……………………………………………………47 
3.3.6 RNA Quantification and Integrity Assessment……………………....47 
3.3.7 Quantitative Real-time PCR (qPCR)………………………………...47 
3.3.8 Agarose Gel Electrophoresis………………………………………...48 
3.3.9 Northern Blot Analysis………………………………………………49 
3.3.9(a) Total RNA Preparation for Denaturing Urea  
  Polyacrlymide Gel Electrophoresis (Urea PAGE)………….49 
3.3.9(b) Denaturing Urea Polyacrlymide Gel Electrophoresis  
  (Urea PAGE)……………………………………………….49 
3.3.9(c) Semi Dry Transblotting……………………………………..50 
3.3.10(d) End-Labeling of Oligonucleotides for  
    Northern Blot Hybridization……………………………...50 
3.3.10(e) Hybridization……………………………………………...50 
3.3.10(f) Post Hybridization Washing……………………………….51 
3.3.10(g) Immunological Detection of Labelled Probes……………..51 
3.4 Computational Analysis……………………………………………………..52 
3.5 Statistical Analysis…………………………………………………………..52 
 
CHAPTER FOUR: RESULTS AND DISCUSSION……………………………..53 
4.1 Biochemical Tests and Verification of Bacterial Strain…………………….53 
ix 
 
4.1.1 Selective Culture Media Confirmation Test………………………...53 
4.1.2 Biochemical Confirmation Tests…………………………………….53 
4.1.3 Serotyping Test……………………………………………………...55 
4.1.4 S. Typhi Biofilm Cell Cultures………………………………………55 
4.1.5 Biofilm Culture Model………………………………………………56 
4.1.5(a) Optimization of Biofilm cells Cultures using  
  6-well Tissue Culture Plates……………………………….56 
4.1.6 Growth Profile of Planktonic, Intermediate and Biofilm Cells………60 
4.1.7 Morphology of Planktonic Cells, Intermediate Cells, and  
Biofilm Cells………………………………………………………...63 
4.2 Total RNA Extraction from Planktonic, Intermediate, and Biofilm Cells......66 
4.2.1 Total RNA Extraction from Planktonic and Intermediate Cells…….66 
4.2.2 Total RNA Extraction from Biofilm Cells…………………………...68 
4.2.3 Quantitative Real-Time PCR (qPCR)………………………………..73 
4.2.4 RNA Integrity of Planktonic, Intermediate, and Biofilm cells……….75 
4.3 Expression Analysis of 10 SPI-Derived ncRNAs in Planktonic,  
Intermediate and Biofilm Cells of S. Typhi…………………………………81 
4.3.1 Expression Profile of StyR-327……………………………………...83 
4.3.2 Expression Profile of StyR-9..……………………………………….88 
4.3.4 Expression Profile of StyR-143……………………………………...92 
4.3.5 Expression Profile of StyR-161……………………………………...96 
            4.3.6 Expression Profile of StyR-381…………………………………….100 
 
CHAPTER FIVE: CONCLUSION……………………………………………...106 
5.1 Conclusion of the Study……………………………………………………106 
5.2 Suggestions for Future Studies……………………………………………..107 
x 
 
REFERENCES……………………………………………………………………108 
APPENDICES 
LIST OF PUBLICATIONS AND PRESENTATIONS 
xi 
 
LIST OF TABLES 
        Page 
 
Table 3.1 List of chemical, media and reagents……………………………….. 24 
 
Table 3.2 Research kits and consumables..……………………………………. 25 
 
Table 3.3 List of software……………………………………………………... 26 
 
Table 3.4 List of instruments………………………………………………….. 26 
 
Table 3.5 List of enzymes……………………………………………………... 27 
 
Table 3.6 List of oligonucleotides used in Northern Blot analysis…………… 27 
 
Table 3.7 List of primers used in quantitative Real-Time PCR analysis……... 28 
 
Table 3.8 Urea PAGE composition…………………………………………… 34 
 
Table 4.1 RNA Yield and Purity Obtained from the Different  
  Phenotype of S. Typhi Cells...……………………………………….,67 
 
Table 4.2 Comparison of the RNA Yield and Purity Obtained by the 
 Seven Total RNA Extraction Methods………………………………71 
 
Table 4.3 csgD Expression Values from qPCR Analysis for Seven  
Different Methods of S. Typhi Biofilm RNA Extraction ……………74 
 
Table 4.4 Expression Profile of Ten SPI-Encoded ncRNAs in  
Planktonic, Intermediate and Biofilm cells of S.Typhi………………82 
  
xii 
 
LIST OF FIGURES 
 
                  Page 
Figure 1.1 Global burden of typhoid fever.  
 (Adapted from Crump et al. 2004)……………………………………2 
 
Figure 1.2 Number of Typhoid fever cases in Malaysia from  
Year 2000-2011. (Data adapted from Disease Control Division,  
Ministry of Health, Malaysia, 2011)………………………………….2 
 
Figure 2.1 S. Typhi is rod shaped, possesses long and peritrichous flagella.  
(Image adapted from http://salmonellatyphi.org/)................................6 
 
Figure 2.2 Trend of typhoid fever cases in Malaysia from year 1997 till 2014. 
(Data adapted from Disease Control Division,  
Ministry of Health, Malaysia, 2015)………………………………….6 
 
Figure 2.3 Trend of typhoid fever cases in Kelantan from year  
1994 till 2014...............................................................................…....7 
 
Figure 2.4 Life cycle of biofilm………………………………………………...12 
 
Figure 2.5 Schematic representation of gene regulation mediated by  
cis-encoded and trans-encoded base-pairing ncRNAs……………...18 
 
Figure 4.1 Selective media culture using XLD agar for S. Typhi  
identification………………………………………………………...54 
 
Figure 4.2 Representative image of the results of biochemical tests for 
confirmation of S. Typhi  …………………………………………...54 
 
Figure 4.3 Comparison of S. Typhi biofilm culture using 2.0 mL  
microcentrifuge tubes and 96-well tissue culture plates.....................58 
 
Figure 4.4 Comparison of S. Typhi biofilm culture on different 6-well  
tissue culture plates………………………………………………….58 
 
Figure 4.5 S. Typhi biofilm culture in 6-well tissue culture plates  
containing cholesterol-coated microscope glass slides.......................59 
 
Figure 4.6 Growth profile of S. Typhi planktonic cells versus  
S. Typhi intermediate cells..…………………………………………62 
 
Figure 4.7 S. Typhi biofilm growth profile……………………………………...62 
Figure 4.8 Transmission Electron Microscope image of S. Typhi planktonic  
cell were grown in nutrient broth………………………………….....64 
 
Figure 4.9 Transmission Electron Microscope image of S. Typhi intermediate  
cells were grown in medium containing bile…………………………64 
xiii 
 
 
Figure 4.10 Scanning electron micrograph revealing a thick biofilm layer 
produced by culture of S. Typhi bacteria in biofilm medium………..65 
 
Figure 4.11 600 ng of total RNA extracted from different stage of  
S. Typhi cells were loaded on 1.2% agarose gel and  
electrophoresed at 100V for 35 min………………………………….67 
 
Figure 4.12 Comparison of Total RNA extraction methods……………………...72 
 
Figure 4.13 Results of electropherograms of Total RNA extracted  
from planktonic S. Typhi cells using the Agilent Bioanalyzer  
RNA 6000 Nano Labchip system. …………………………………..78 
 
Figure 4.14 Results of electropherograms of Total RNA extracted  
from intermediate S. Typhi cells using the Agilent Bioanalyzer  
RNA 6000 Nano Labchip system …………………………………...79 
 
Figure 4.15 Result of electropherograms of Total RNA extracted from  
S. Typhi biofilm cells using the Agilent Bioanalyzer RNA  
6000 Nano Labchip system………………………………………….80 
 
Figure 4.16 Expression profile of StyR-327 ncRNA and 5S rRNA in S. Typhi….84 
 
Figure 4.17 StyR-327 target interaction predictions via RNAPredator  
web server.………………………………………………………......85 
 
Figure 4.18 Enzymatic reaction by transport of methyl-β-D-galactoside  
(methyl-β-D-galactoside / galactose ABC transporter)  
(Image adapted from http://ecocyc.org)..............................................87 
 
Figure 4.19 Expression profile of StyR-9 ncRNA and 5S rRNA in S. Typhi…….89 
 
Figure 4.20 StyR-9 target interaction predictions via RNAPredator web server…90 
 
Figure 4.21 Expression profile of StyR-143 ncRNA and 5S rRNA in S. Typhi….93 
 
Figure 4.22 StyR-143 target interaction predictions via RNAPredator web  
server………………………………………………………………...94 
 
Figure 4.23 Expression profile of StyR-161 ncRNA and 5S rRNA in S. Typhi….97 
 
Figure 4.24 StyR-161 target interaction predictions via RNAPredator web 
server………………………………………………………………...98 
 
Figure 4.25 Expression profile of StyR-381 ncRNA and 5S rRNA in S. Typhi…101 
 
Figure 4.26 StyR-381 target interaction predictions via RNAPredator web 
server……………………………………………………………….102 
 
xiv 
 
Figure 4.27 Schematic representations of SPI-derived ncRNA candidates  
taken from Chinni et al., 2010...……………………………………104 
  
xv 
 
LIST OF SYMBOLS, ABBREVIATIONS AND ACRONYMNS 
 
 
-    Negative or minus 
%    Percentage 
~    Approximately 
<    Less than 
>    More than 
µg    Microgram 
µL    Microliter 
10X    Ten times 
1X    1 time 
bp    Base pair 
cm    centimetre 
DNA     Deoxyribonucleic acid 
dNTP    Deoxynucleoside triphosphate 
E. coli    Escherichia coli 
g    gram 
IgG    Immunoglobulin G 
L    Liter 
LA     Luria agar 
LB    Luria broth 
M    Molar 
MDR    Multidrug resistant 
mg     Milligram 
mL    Milliliter 
mM     Millimolar 
ncRNA   Non-coding RNA 
ng    Nanogram 
ºC    Degree Celcius 
OD     Optical Density 
OMP    Outer membrane protein 
PBS    Phosphate-buffer saline 
pH     Power of hydrogen 
psi    Pounds per square inch 
RNA    Ribonucleic acid 
S. Typhi   Salmonella Typhi 
SEM    Scanning Electron Microscope 
SPI    Salmonella Pathogenicity Island 
v/v    Volume per volume 
w/v    Weight per volume 
  
xvi 
 
KAJIAN RNA KECIL BUKAN PENGEKODAN DARIPADA SALMONELLA 
ENTERICA SUBSPECIES ENTERICA SEROVAR TYPHI DALAM 
PERTUMBUHAN BIOFILEM 
 
ABSTRAK 
Salmonella Typhi adalah Gram-negatif bakteria dan patogen khusus bagi 
manusia yang menyebabkan demam kepialu. Ia merupakan masalah kesihatan yang 
serius di negara-negara yang kurang membangun dan sedang membangun termasuk 
Malaysia. Salah satu faktor utama yang menyumbang kepada penyebaran demam 
kepialu ialah kewujudan pembawa kepialu asimptomatik. Pembentukan biofilm dalam 
pundi hempedu manusia dikaitkan rapat dengan perkembangan pembawa. Kajian 
terkini menunjukkan, 97 novel RNA kecil bukan pengekodan (ncRNAs) yang dikenal 
pasti dari S. Typhi sel melalui eksperimen makmal. Daripada 97 ncRNAs, sepuluh 
daripadanya dikategorikan dalam ‘Salmonella Pathogenicity Island’ (SPI). RNA kecil 
bukan pengekodan adalah molekul RNA yang tidak mengekod protein tetapi terlibat 
dalam modulasi proses kawal selia sel, termasuk patogenesis bakteria. Oleh itu, tujuan 
utama kajian ini adalah untuk mengenalpasti peranan sepuluh ncRNAs dari SPI dalam 
pembentukan biofilem. Untuk menghasilkan jumlah sel biofilem yang banyak, satu 
model biofilem baru direka dengan menggunakan slaid kaca mikroskop yang bersalut 
kolesterol diletakkan dalam 6-lubang kultur tisu plat. Tujuh kaedah pengekstrakan 
RNA telah dinilai untuk mengenal pasti kaedah pengekstrakan RNA yang berkesan 
daripada sel biofilem. Ianya terdiri daripada empat kit komersial: 1) RNeasy Mini Kit 
(Qiagen, Germany), 2) NucleoSpin RNA II (Macherey-Nagel, Germany), 3) Phenol-
Free Total RNA Purification Kit (Amresco, USA), and 4) Total RNA Purification Kit 
(Norgen, Canada), dan tiga kaedah pengekstrakan yang berbeza iaitu 1) pengekstrakan 
xvii 
 
yang menggunakan enzim lysis, 2) sonikasi, dan 3) pengeskstrakan yang 
menggunakan pemukul manik. Hasilnya, kaedah pemukul manik dengan TRIzol lebih 
baik dan mampu untuk mengeskstrakan kuantiti RNA yang tinggi dan berkualiti dari 
biofilem S. Typhi berbanding dengan kaedah lain. Degradasi 23S RNA juga 
dikenalpasti apabila sel S. Typhi memasuki fasa kebuluran. Jumlah RNA dari sel 
plankton, pertengahan dan biofilem dianalisi dengan mengunakan kaedah blot 
northern. Pelabelan menggunakan digoxigenin bukan radioaktif (DIG) telah 
digunakan dalam blot Northern untuk mengesan sepuluh ncRNA yang diperolehi 
dalam SPI. Daripada sepuluh ncRNAs ini, lima ncRNAs ekspresi, iaitu Styr-327, Styr-
9, Styr-143, Styr-161, dan Styr-381, telah dikesan. Styr-161 menunjukkan kuantiti 
ekspresi yang serata dalam semua 3 peringkat sel S. Typhi, mencadangkan ia boleh 
dikategorikan gen juzuk dalam sel S. Typhi. Styr-9 dan Styr-381 menunjukkan 
ekspresi yang rendah dalam sel-sel biofilem berbanding dengan sel-sel plankton. 
Manakala, Styr-143 dan Styr-327 jelas menunjukkan ekspresi yang tinggi dari sel-sel 
pertengahan dan biofilem berbanding dengan sel-sel plankton. Oleh itu, ncRNA ini 
mungkin mempunyai peranan yang penting dalam penyesuian biofilm. Menariknya, 
Styr-143 hanya diekspres semasa sel-sel pertengahan dan sel-sel biofilem, 
menunjukkan peranan penting dalam pembentukan biofilem. Sasaran mRNA 
diramalkan bagi ncRNAs yang dikenalpasti dengan menggunakan pelayar laman web 
yang dikenali sebagai 'RNAPredator’ dan fungsi kemungkinan ncRNAs ini ke arah 
sasaran mRNA diandaikan dalam kajian ini. Akhir sekali, ncRNAs yang dikaitkan 
dengan biofilem yang telah dikenal pasti dalam kajian ini boleh berfungsi sebagai 
bakal calon penanda bio untuk mengenal pasti pembawa Kepialu dan memberikan 
petunjuk untuk lebih memahami fungsi kawal selia dalam pembentukan biofilem. 
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A STUDY OF SMALL NON-CODING RNAs OF SALMONELLA ENTERICA 
SUBSPECIES ENTERICA SEROVAR TYPHI IN BIOFILM DEVELOPMENT 
 
ABSTRACT 
Salmonella Typhi is a Gram-negative bacteria and human-specific pathogen 
which causes Typhoid fever. It is a major health problem in under-developed and 
developing countries including Malaysia. One of the major factors contributing to 
Typhoid persistence is due to the existence of asymptomatic Typhoid carriers. Biofilm 
formation in the human gallbladder has been postulated to be associated with the 
development of carriers. A recent study found 97 novel non-coding RNAs (ncRNAs) 
in S. Typhi and ten of them were mapped to the Salmonella Pathogenicity Island (SPI) 
of the bacteria’s genome. Non-coding RNAs are RNA molecules that do not encode 
for proteins but are involved in modulating cell regulatory processes, including 
bacterial pathogenesis. Thus, the main aim of this study was to explore the role of the 
ten SPI-derived ncRNAs in biofilm formation. To produce a higher amount of biofilm 
cells, a new biofilm culture model was developed on a cholesterol-coated microscope 
glass slide in a 6-well tissue culture plate. Seven RNA extraction methods consisting 
of 4 different commercially available RNA extraction kits and 3 in-house methods 
were studied in order to identify effective RNA extraction methods from biofilm cells. 
The commercial kits were; 1) RNeasy Mini Kit (Qiagen, Germany), 2) NucleoSpin 
RNA II (Macherey-Nagel, Germany), 3) Phenol-Free Total RNA Purification Kit 
(Amresco, USA), and 4) Total RNA Purification Kit (Norgen, Canada). The 3 different 
in-house extraction methods were; 1) enzymatic lysis, 2) sonication, and 3) bead-
beater with TRIzol. The results showed that the bead beater with TRIzol extraction 
method was better and could produce high quantity and quality of RNA from S. Typhi 
xix 
 
biofilm compared to the other methods. Kinetic studies of S. Typhi cultures showed 
degradation of 23S RNA when the S. Typhi cell entered into starvation phase. The 
extracted total RNA from planktonic, intermediate and biofilm cells were then 
subjected to northern blot analysis using non-radioactive digoxigenin (DIG) method 
to the detect ten SPI-derived ncRNAs. Out of these ten ncRNAs, five ncRNAs, i.e. 
StyR-327, StyR-9, StyR-143, StyR-161, and StyR-381 were detected. StyR-161 was 
equally expressed in all three stages of S. Typhi development, suggesting a house-
keeping function in S. Typhi cells. StyR-9 and StyR-381 were marginally down-
regulated in the biofilm cells compared to the planktonic cells, whereas StyR-143 and 
StyR-327 were clearly up-regulated in the intermediate and biofilm cells compared to 
the planktonic cells, indicating a possible role of these ncRNAs in biofilm adaptation. 
Interestingly, StyR-143 was found to be expressed only in intermediate cells and 
biofilm cells, indicating a specific role in biofilm formation. The possible mRNA 
targets of these ncRNAs was predicted using an online webserver known as 
‘RNAPredator’, and the possible functions of these ncRNAs towards their mRNA 
target were postulated. Finally, the biofilm-associated ncRNAs that were identified in 
this study can serve as biomarker candidates for Typhoid carrier identification and 
provide clues to better understand the regulatory functions in biofilm. 
 
 
1 
     
CHAPTER ONE 
INTRODUCTION 
 
Typhoid fever is a global infectious disease with an estimated incidence of 26.9 million 
cases and 269,000 deaths per annum (Buckle et al., 2012). Salmonella enterica 
subspecies enterica serovar Typhi (S. Typhi) is the pathogen responsible for Typhoid 
fever. Salmonella is a Gram-negative bacterium that belongs to the Enterobacteriaceae 
family. This pathogen is rod-shaped and generally motile. It is a human-specific 
pathogen and humans are the only known reservoir or carriers of the disease. 
According to the World Health Organization, the disease occurs mainly in Asia and 
Africa (Figure 1.1), where the annual incidence of Typhoid fever is about 1-100 cases 
per 100,000 population (Crump & Mintz, 2010; Crump et al., 2004)  
 
Typhoid fever is a systemic disease that is transmitted through faecal-oral route via 
ingestion of faecal-contaminated water or food. Although it is an ancient disease, 
Typhoid fever still continues to be a global health problem especially in developing 
and under-developed countries, where poor sanitation and inadequate access to clean 
water facilitate the spread of the disease (Crump & Mintz, 2010). In the year 2005, the 
Ministry of Health, Malaysia reported 1,072 cases of Typhoid fever in the country 
(Figure 1.2). 
 
The disease is characterized by high fever, malaise, nausea, vomiting, and diarrhea. 
Following ingestion, S. Typhi penetrate intestinal epithelium and invades 
macrophages. The infected macrophages carry the organism to the systemic circulation 
infecting the liver, pancreas, and spleen, causing acute fever (Gonzalez-escobedo et  
2 
     
Figure 1.1: Global burden of typhoid fever. (Adapted from Crump et al., 2004) 
 
 
 
 
 
  
Figure 1.2: Number of Typhoid fever cases in Malaysia from year 2000-2011. 
(Data adapted from Disease Control Division, Ministry of Health, Malaysia, 
2011) 
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al., 2011). From the liver, the bacteria migrates to the gallbladder, where either an 
active infection (cholecystitis) or a chronic infection (carrier state) may develop. The 
carrier state occurs in about 3 to 5% of people infected with acute Typhoid fever, and 
is frequently associated with gallbladder abnormalities and cancer (Gunn et al., 2014; 
Prouty et al., 2002). 
 
Chronic infection with S. Typhi is associated with long-term localization of the 
bacteria in the gallbladder and continual excretion of the bacilli in the faeces which 
can result in outbreaks of the disease in the community. The ability of S. Typhi to 
survive in the gallbladder is due to its ability to form biofilm on the surface of human 
cholesterol gallstones. Biofilms are generally defined as a community of bacteria 
adherent on a surface and protected by a layer of exopolysaccharide matrix (Gunn et 
al., 2014). Biofilm formation is believed to be a protective mechanism of the bacteria 
in response to harsh conditions, such as environmental stresses, antibiotics, 
disinfectants and the host immune system (Pamp et al., 2007). As such, it is considered 
a pathogenic feature of S. Typhi. However, the mechanisms associated with biofilm 
genesis is poorly understood. 
 
Recent studies have shown that the expression of non-coding RNAs plays a critical 
role in the growth of this pathogen. Ninety-seven unique sRNAs have been found in 
S. Typhi in which ten were mapped to the Salmonella Pathogenesis Island (SPI) genes, 
suggesting their importance in the pathogenesis of the organism (Chinni et al., 2010). 
Since biofilm formation is associated with the bacterial virulence, it is hypothesised 
that some of these non-coding RNAs are involved in the biofilm formation. Therefore, 
this project was aimed at investigating the expression of the ten unique non-coding 
4 
     
RNAs in S. Typhi in order to understand their role in the formation of biofilm in S. 
Typhi. 
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CHAPTER TWO 
LITERATURE REVIEW 
 
2.1 The Genus Salmonella 
Salmonella are Gram-negative bacteria that belong to the Enterobactericeae family. 
These pathogens are rod-shaped and generally motile with peritrichous flagella 
(flagella that are all around the cell body) except for Salmonella gallinarum (Andino 
& Hanning, 2015). The genus Salmonella is classified into two different species; 
Salmonella enterica and Salmonella bongori, which can be further subdivided into 
subspecies and serotypes (serovar). So far, more than 2,500 serotypes have been 
identified (Jones et al., 2008). 
 
2.2 Salmonella enterica subspecies enterica serovar Typhi 
Among 2,500 serotypes, Salmonella enterica subspecies enterica serovar Typhi (S. 
Typhi), is the only pathogen responsible for Typhoid fever. It is a human-specific 
pathogen and human are the sole reservoir for S. Typhi. Typhoid fever is still a global 
infectious disease with an estimated count of 26.9 million cases and 269,000 deaths 
per annum (Buckle et al., 2012). This systemic disease is transmitted through faecal-
oral route via ingestion of contaminated water or food mainly by faeces or urine. The 
infected patients usually show a few common symptoms, such as abdominal pain, 
dizziness, high fever, and in some severe cases it can be life threatening 
 
2.3 Typhoid Fever 
Worldwide, Typhoid fever continues to be a threat to global health problem especially 
in under-developed and developing countries where poor sanitation and inadequate  
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Figure 2.1: S. Typhi is rod-shaped, possesses long and peritrichous flagella. 
(Image adapted from http://salmonellatyphi.org/) 
 
 
 
 
Figure 2.2: Trend of typhoid fever cases in Malaysia from year 1997 till 2014. 
(Data adapted from the Disease Control Division, Ministry of Health, Malaysia, 
2015) 
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Figure 2.3: Trend of typhoid fever cases in Kelantan from year 1994 till 2014. 
(Data from Kelantan State Public Health Department, 2015) 
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access to clean water facilitated the spread of the disease (Crump & Mintz, 2010). 
 
 
Asia was reported to have the highest incidence rate of typhoid fever, especially in 
South-central and South-eastern Asia, including Malaysia, India, Pakistan, and 
Bangladesh with more than 100 cases per 100,000 population in the year 2000 (Crump 
et al., 2004). However, according to the data collected by the Ministry of Health, 
Malaysia was classified as a low endemic region for typhoid fever with an annual 
incidence rate of less than 10 cases per 100,000 population from year 1997 to 2014 
(Figure 2.2).  Among all the states in Malaysia, Kelantan has the highest incidence rate 
of typhoid fever and classified as a medium endemic region (10-100 per 100,000) 
(Shah et al., 2012). The annual typhoid incidence estimated in year 2001 for Kelantan 
was 37 per 100,000 (Wan Mansor et al., 2005), which declined to 24.4 per 100,000 in 
2003, 10 per 100,000 in 2008, 3.29 per 100,000 in 2009, and 2.8 per 100,000 in year 
2010. This was attributed to the introduction of proper monitoring and surveillance 
systems by the Kelantan State Public Health Department (Wan Mansor et al., 2011). 
As shown in Figure 2.3, a highest incidence of typhoid fever occurred in the year 2005 
due to a major flood in the state. It was reported that wells were contaminated with 
sewage overflow, and rural communities which depended on wells for water supply 
were infected (Shah et al., 2012). 
 
2.4 Pathogenesis and Clinical Manifestations 
The incubation period of S. Typhi is generally 7 to 14 days, even though it may be as 
short as 3 and as long as 60 days depending upon the size of the inoculum and the 
status of the hosts immune system (Crump & Mintz, 2010; Crump et al., 2004; 
Maskalyk, 2003). In the first week of infection, gastrointestinal manifestations, such 
as abdominal pain and diarrhea are the first symptoms that happen to most people. 
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Constipation may also occur as the Peyer’s Patches undergo inflammation and 
narrowing of the bowel lumen (Gunn et al., 2014). Some individuals may also develop 
headache, dry cough and delirium, which leads to malaise (WHO, 2003).  
 
After ingestion, S. Typhi is able to survive the acidic barrier in the stomach and 
colonize the small intestine (Gunn et al., 2014). The bacterium crosses the intestinal 
epithelium via three routes: (i) active invasion of enterocytes; (ii) passive invasion of 
M cells in the Peyer’s Patches (lymphoid associated tissue of the distal ileum); and 
(iii) direct uptake by CD18+ cells (macrophage’s or dendritic cells) that intercalate 
epithelial cells by extending protrusions into the gut lumen (Álvarez-Ordóñez et al., 
2011; Crump et al., 2004; Gonzalez-escobedo et al., 2011). 
 
The invading bacteria from the first two routes are internalized by macrophages and 
dendritic cells which reside in the lamina propria. S. Typhi infected phagocytes migrate 
to the intestinal lymphoid follicles and the draining mesenteric lymph nodes and spread 
systemically via lymph and blood (Gonzalez-escobedo et al., 2011). The most 
common sites of secondary infection are the liver, spleen, bone marrow and the 
gallbladder. The bacteria reaches the gallbladder via the vasculature or through the 
ducts emanating from the liver (Gonzalez-escobedo et al., 2011). Bacteria that are 
excreted in the bile can then reinvade the intestinal wall. The gallbladder is the main 
reservoir during a chronic infection with S. Typhi as the bacteria are able to overcome 
the toxic effect of bile (Gonzalez-escobedo et al., 2011; Gunn et al., 2014). 
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2.5 Typhoid Carriers 
Most Typhoid fever patients recover from the acute phase of the disease after adequate 
treatment; however, between 3 to 5% of individuals infected with S. Typhi develop a 
chronic infection in the gallbladder regardless of treatment (Maskalyk, 2003). Chronic 
carriers are defined as individuals shedding S. Typhi in their feces more than 1 year 
after the acute infection (Gonzalez-escobedo et al., 2011). As S. Typhi is a human-
restricted pathogen, chronic carriers serve as a critical reservoir for further spread of 
the disease through persistent bacterial shedding in feces and urine (Gunn et al., 2014; 
Prouty et al., 2002). Chronic S. Typhi infections can persist for decades and although 
highly contagious, they are typically asymptomatic, making identification of carriers 
within a population difficult (Gonzalez-escobedo et al., 2011). 
 
Besides that, chronic carriage also presents a high possibility of developing gallbladder 
cancer (Gonzalez-escobedo et al., 2011). The uniqueness of S. Typhi is its ability to 
interact with bile, a highly complex, lipid-rich and protein-poor digestive secretion 
produced by the liver. The components of bile are include bile acids, cholesterol, 
bilirubin and phospholipids and functions as a potent antimicrobial substance in the 
gastrointestinal tract (Gonzalez-escobedo et al., 2011). However, the primary site of 
S. Typhi carriage is in the bile rich gallbladder, which proposes a dilemma. How does 
S. Typhi develop resistance mechanisms which are utilised by the bacteria to develop 
resistance and persistence in this hostile environment (Gonzalez-escobedo et al., 
2011).  Therefore, the survival of the bacteria in the gallbladder is a key to understand 
bacteria persistence and biofilm formation must be a critical method. 
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2.6 Bacterial Biofilm 
A bacterial biofilm can be defined as a community of bacteria adherent to a surface 
and each other by an extracellular matrix secreted by the bacterial cells (Sutherland, 
2001). Bacterial preference to survive in groups attached to surfaces and biofilms were 
seen as simply “chunks” of randomly positioned bacteria within a matrix material. 
However, it has been discovered that biofilms are not stationary cells or inactive 
groups of cells but in fact they were complex, diverse community of cells with an 
ordered and efficient three dimensional structure (Gerstel & Römling, 2003; 
Sutherland, 2001). A biofilm community has a large benefit to an individual bacterium, 
protection from environmental stress where the bacteria can be shredded via an 
extracellular matrix. Hence, at the same time bacterial cells receiving all of the 
nutrients needed to survive from the extracellular matrix (McDougald et al., 2011). 
 
2.7 Life Cycle of Biofilm 
Biofilm formation begins with a few free swimming planktonic cells attaching 
themselves onto a desired surface. The attached surface could be a biotic surface, such 
as animal cells, plant cells, or abiotic surface, such as gallstones or polystyrene 
materials (Sutherland, 2001). There are four distinct stages in the formation of biofilm 
for most bacteria species: surface attachment, development of microcolonies, mature 
biofilm, and finally dispersion (Figure 2.4). The attachment stage is believed to be 
irreversible as most of the attached cells lose their flagella and motility (Monroe, 
2007). The attached cells eventually form an extracellular matrix known as 
exopolysaccharide (EPS) (McDougald et al., 2011). The EPS matrix provides 
structural support and protection for the cells within it. As the biofilm matures, the 
biofilm structure becomes more complex. When the biofilm reaches a certain maturity   
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Figure 2.4: Life cycle of biofilm. Stage 1, the planktonic cells attach onto a surface. 
Stage 2, the surface-attached cells form a layer of protective matrix which later 
becomes the biofilm community. Stage 3, the biofilm becomes mature. Stage 4, 
dispersion of the bacteria into the environment. (Adapted from Chung & Toh, 
2014) 
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level, planktonic cells or a portion of the biofilm may disperse into the environment looking 
for another habitat (Pamp et al., 2007). 
 
2.8 Salmonella Biofilm Matrix 
In the biofilm, bacteria cell are embedded in EPS the matrix. The EPS matrix is usually 
produced by the bacteria itself and can be hydrophilic or hydrophobic. It is composed 
approximately 97% of water (Pamp et al., 2007; Sutherland, 2001). Thus, with 
hydrated matrix, desiccation of the biofilm can be prevented. Beside water, the EPS 
matrix also contains cellulose, curli, fimbriae, colanic acid, biofilm related proteins 
and nucleic acids (Götz, 2002). The EPS matrix components of Salmonella biofilms 
vary considerably with the environmental conditions and the type of surface (Prouty 
et al., 2002). The mixed components in the bacterial biofilms provide rigidity to the 
biofilm and protection for the bacterial cells embedded within the biofilm. 
 
Flagella has been shown to promote surface binding during the initial stages of biofilm 
development in various microorganisms (Sutherland, 2001). The expression of S. 
Typhimurium flagella was to be up-regulated in biofilm formation on polystyrene 
wells and glass surfaces (Prouty et al., 2002), and directly facilitates the biofilm 
development on cholesterol coated surfaces, suggesting its contribution of this surface 
appendage to biofilm formation varies with binding substrates (Crawford et al., 2008). 
It has been reported that, the conserved S. Typhimurium flagellar regulon gene flhE, 
involved in the flagellar type III secretion specificity switch, is not required for flagella 
production or swimming, but appeared to play a role in swarming and biofilm 
formation (Davies et al., 1993).  
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In addition, fimbriae has been shown to facilitate adherence during biofilm initiation 
(attachment stage) and cell-cell interactions during growth of Salmonella biofilm 
(Müsken et al., 2010). Moreover, curli fimbriae (thin aggregative fimbriae) are 
amyloid-like cell-surface proteins and it is important in host-colonization, persistence, 
invasion and host-immune evasion (Bordeau & Felden, 2014; Steenackers et al., 
2012). Colanic acid and cellulose are capsular extracellular polysaccharide that plays 
a role in Salmonella biofilm formation, specifically to create extensive three-
dimensional structures (Crawford et al., 2008).  
 
The O-antigen that is conserved amongst Salmonella species consisting of more than 
2,300 repeating tetrasaccharide units. Structurally, the O-antigen capsule is similar to 
Lipopolysaccharides (LPS) O-antigen of S. Enteritidis, and have similar repeating 
sugar units. The LPS O-antigen differs in size, charge, substitution patterns, and 
immunoreactivity (Pamp et al., 2007). The O-antigen capsule is postulated to play an 
important role in environmental persistence (Gibson et al., 2006). Furthermore, 
production of O-antigen capsule in S. Typhimurium was shown to be related to murine 
infection activity, suggesting involvement in systemic infection and the cause of 
Typhoid fever outbreaks (Barak et al., 2007). The O-antigen capsule was also shown 
to be a crucial determinant of biofilm culture on gallstones and cholesterol-coated 
surfaces (Crawford et al., 2008). 
 
There are many genes known to regulate the expression of biofilm extracellular matrix 
components via CsgD, a transcriptional activator of the curli operons as well as other 
biofilm related operons, adrA, bapA, and bcsABCD (Gerstel & Römling, 2003) . CsgD 
is the master curli regulator in S. Typhi biofilm and other Gram-negative bacteria. It 
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was found that in E. coli biofilm, CsgD also altered the cell physiology to enable 
production of curli (Beloin et al., 2004). Biosynthesis of cellulose at the inner bacterial 
membrane is also positively regulated by CsgD via direct binding and subsequent 
transcriptional stimulation of AdrA in S. Typhimurium biofilm (He & Ahn, 2011; 
Wang et al., 2015). Therefore, the CsgD can be seen as the biofilm control point by 
regulating the expression of all major Salmonella biofilm constituents and controlling 
the transition between planktonic cells to biofilm cells (Gerstel & Römling, 2003; 
Wong, 2011). Moreover, the csgD expression is also influenced by a large number of 
proteins, non-coding RNA and signalling molecules (Gerstel & Römling, 2003; Wang 
et al., 2015). This complex regulation allows csgD expression to respond to a number 
of different extracellular inducements, such as pH, temperature, salt concentration, and 
nutrient supply amongst others (Gerstel & Römling, 2003; Wang et al., 2015; Zou et 
al., 2012). Recent studies also show that non-coding RNAs (ncRNAs) are involved in 
bacteria cellular network which, include biofilm regulation, bacterial virulence, and 
also response to environmental stress (Chambers & Sauer, 2013; Finnegan & Matzke, 
2003; Gripenland et al., 2010). 
 
2.9 Non-Coding RNA 
Two major classes of RNA types have been identified in cells derived from all 
organisms: 1) Protein-coding RNAs or mRNAs serve as templates for protein 
synthesis; 2) non-coding RNAs (ncRNAs) that are not translated into protein but act 
as functional RNA (Finnegan & Matzke, 2003; Michaux et al., 2014). As the name 
suggests, ncRNAs do not encode for proteins as they do not contain open reading 
frames (ORFs). However, this does not mean that they do not contain information nor 
have function. These regulatory RNAs, which are also widely known as small RNAs 
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(sRNAs), non-protein-coding RNAs (npcRNAs), functional RNAs (fRNAs), 
untranslated RNAs (utRNAs), and small non-messenger RNAs (snmRNAs) (Finnegan 
& Matzke, 2003; Gripenland et al., 2010; Storz et al., 2011). The ncRNAs are present 
in all kingdoms of life forms and have become increasingly recognized as a novel class 
of gene expression regulators and play many indispensable roles in bacterial cells. The 
ncRNAs are generally between 50–300 nucleotides in length (Finnegan & Matzke, 
2003). They play diverse physiological roles, such as those in the regulation of stress 
responses and metabolism, control of bacterial envelope composition, RNA processing 
and modification, mRNA stability and translation, transcriptional regulation, protein 
stability and secretion (Chowdhury et al., 2013; Michaux et al., 2014; Romilly et al., 
2014; Vogel, 2009). In addition, ncRNAs also play vital regulatory roles in bacterial 
virulence and quorum sensing besides being involved in many aspects of microbial 
physiology such as, regulation of outer membrane protein synthesis, iron homeostasis 
and nutrient metabolism (Bejerano-Sagie & Xavier, 2007; Gripenland et al., 2010). 
 
Most characterized ncRNAs regulate gene expression by base pairing with the target 
mRNAs with having extensive potential for base pairing with their target ncRNA or 
those with more limited complementarity (Storz et al., 2011; Waters & Storz, 2009). 
The ncRNAs regulation or interaction can be classified into two distinct classes based 
on their genomic locations: 1) cis-encoded ncRNAs and 2) trans-encoded ncRNAs 
(Papenfort & Vogel, 2010; Storz et al., 2011; Waters & Storz, 2009).  
 
2.10 Cis-encoded base pairing Non-Coding RNAs 
In bacteria, cis-encoded base pairing occurs when the ncRNA binds with extensive 
complementarity to their target mRNAs, and they are located on the DNA strand 
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opposite to the mRNA targets. Even though the two transcripts are encoded in the same 
region of DNA, the able to transcribe from opposite strands as discrete RNA type, and 
mostly it functions as a trans as diffusible structural unit or molecules (Waters & Storz, 
2009). The cis-encoded antisense sRNAs mostly exist in plasmids or other Mobile 
Genetic Elements (MGE) (type of DNA that can move around within the genome). 
However, these ncRNAs are increasingly being found in chromosome. Most of the cis-
encoded antisense sRNAs expressed from plasmids, bacteriophage, and transposons 
function to maintain the appropriate copy number of the MGE (Brantl, 2009). In 
addition, cis-encoded antisense sRNAs modulate the riboswitches, which are part of 
the 5’UTRs of their target mRNA, that undergoes change in their structures upon 
binding of a regulatory molecule (Figure 2.5). Moreover, the physiological roles of the 
cis-encoded antisense ncRNAs expressed from bacterial chromosomes promotes 
degradation or represses translation of mRNAs (De Lay et al., 2013; Waters & Storz, 
2009).  
 
It has been reported that in E. coli, base-pairing between the stationary phase-induced 
GadY antisense ncRNA and the gadXW mRNA leads to cleavage of the duplex 
between the gadX and gadW genes (Padalon-Brauch et al., 2008). In cyanobacterium 
Synechocystis, the iron stress-repressed IsrR antisense ncRNA base pairs with 
sequences within the isiA coding region of the isiAB transcript and leads to decreased 
levels of an isiA transcript (Dühring et al., 2006; Waters & Storz, 2009). 
 
2.11 Trans-encoded base pairing Non-Coding RNAs 
Another class of base-pairing ncRNAs is the trans-encoded ncRNA, where this type 
ncRNAs only share limited complementarity with their target mRNAs. They generally  
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Figure 2.5: Schematic representation of gene regulation mediated by Cis-encoded 
and trans-encoded base-pairing ncRNAs. (A) Gene encoding cis-encoded antisense 
sRNAs/ncRNA (red) and their target RNAs (blue), which share extensive 
complementarity. An sRNA/ncRNA encoded opposite to the 5’ UTR of its target 
mRNA. Base-pairing inhibits ribosome binding and often leads to target mRNA 
degradation. Base-pairing of the sRNA/ncRNA can target RNases to the region and 
cause mRNA cleavage, with various regulatory effects, or the sRNA/ncRNA can cause 
transcriptional termination, leading to reduced levels of downstream genes. (B) Genes 
encoding trans-encoded antisense sRNAs/ncRNAs (red) are located separately from 
the genes encoding their target RNAs (blue) and only have limited complementarity. 
Trans-encoded ncRNA can act negatively by base pairing with the 5’ UTR and 
blocking ribosome binding and/or targeting the ncRNA-mRNA duplex for degradation 
by RNases (middle panel). Trans-encoded ncRNA can act positively by preventing the 
formation of an inhibitory structure, which sequesters the ribosome-binding site 
(RBS). (Adapted from Waters & Storz, 2009) 
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act by base pairing with target mRNAs with imperfect base-pairing/less 
complementarity (Storz et al., 2011; Waters & Storz, 2009). The interaction of 
ncRNAs to the complementarity mRNA are usually short and non-contiguous. Many 
of these ncRNAs base-pair at or near to the ribosome binding site (RBS) of their targets 
mRNA and block translation by blocking ribosomes (Figure 2.5) (Waters & Storz, 
2009). 
 
In addition, the trans-encoded ncRNAs can complement with their target mRNA at a 
more distant location and thus interfere with ribosome binding site by preventing the 
formation of inhibitory secondary structures, or decrease or increase mRNA stability 
(Storz et al., 2011; Waters & Storz, 2009). Since they usually interact with their targets 
via imperfect base-pairing, these npcRNAs usually require the aid of RNA chaperone, 
bacterial RNA binding protein (Hfq). The binding of Hfq is believed to stimulate base 
pairing interactions by remodelling RNA structures and by increasing local 
concentrations of mRNA and the ncRNAs (De Lay et al., 2013).  
 
2.12 Non-Coding RNA in Biofilm 
In S. Typhimurium biofilm, it has been reported that biofilm formation phenotype is 
dependent on the ncRNA called MicA, encoded in the LuxS gene. MicA is partially 
regulated by a quorum sensing system and specifically by the enzyme LuxS (Kint et 
al., 2010). In addition, MicA also involve in the regulation of biofilm formation via 
RNA chaperone protein (Hfq).  The Hfq is a prerequisite for the binding of many 
ncRNAs to their trans-encoded targets which are involved in the transcription of 
several ncRNAs, including MicA (Kint et al., 2010)  
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The 93 nucleotide MicF sRNA forms a 20 base-pair imperfect RNA duplex with the 
translation initiation region of ompF mRNA in order to negatively regulate expression 
of this outer membrane protein (OMP) at the post-transcriptional level (Bak et al., 
2015) . The Outer membrane (OM) is an important component of Gram-negative 
bacteria. Together with the peptidoglycan layer and the inner membrane, it forms the 
bacterial cell envelope in S. Typhimurium biofilm. The OM functions as a selective 
barrier that prevents the entry of many toxic molecules into the biofilm cell, and plays 
a vital role in bacterial survival in biofilm in diverse environments. So the MicA 
strongly requires Hfq for its own intracellular stability and for annealing to mRNA 
(Van Puyvelde et al., 2013). 
 
In E. coli biofilm, the Csr (carbon storage regulatory) system exerts profound effects 
on biofilm development. A CsrA ncRNA regulates E. coli biofilm formation by post 
transcriptionally repressing genes required for the production of polysaccharide 
adhesion of the biofilm (Romeo, 1998). In addition, CsrB and CsrC ncRNAs are part 
of the Salmonella Csr system and antagonize the activity of the RNA-binding protein.  
 
Even though a lot of research on ncRNA related biofilm has been carried out today, 
there is still no study carried out on S. Typhi biofilm. So, this study will focus on 
ncRNA regulation in S. Typhi biofilm. 
 
2. 13 Rational of the Study 
Few research has been carried out on S. Typhi, the pathogen that causes Typhoid fever 
in humans. Whereas, S. Typhimurium which causes Typhoid-like symptoms in mice, 
is frequently used as the experimental model to study Salmonella virulence, since 
